Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200564508> ?p ?o ?g. }
- W4200564508 endingPage "e0261269" @default.
- W4200564508 startingPage "e0261269" @default.
- W4200564508 abstract "Adeno-associated viruses (AAV) are considered non-pathogenic in humans, and thus have been developed into powerful vector platforms for in vivo gene therapy. Although the various AAV serotypes display broad tropism, frequently infecting multiple tissues and cell types, vectors for specific and efficient targeting of human CD4+ T lymphocytes are largely missing. In fact, a substantial translational bottleneck exists in the field of therapeutic gene transfer that would require in vivo delivery into peripheral disease-related lymphocytes for subsequent genome editing. To solve this issue, capsid modification for retargeting AAV tropism, and in turn improving vector potency, is considered a promising strategy. Here, we genetically modified the minor AAV2 capsid proteins, VP1 and VP2, with a set of novel nanobodies with high-affinity for the human CD4 receptor. These novel vector variants demonstrated improved targeting of human CD4+ cells, including primary human peripheral blood mononuclear cells (PBMC) and purified human CD4+ T lymphocytes. Thus, the technical approach presented here provides a promising strategy for developing specific gene therapy vectors, particularly targeting disease-related peripheral blood CD4+ leukocytes." @default.
- W4200564508 created "2021-12-31" @default.
- W4200564508 creator A5007918042 @default.
- W4200564508 creator A5014126648 @default.
- W4200564508 creator A5017998451 @default.
- W4200564508 creator A5021045594 @default.
- W4200564508 creator A5032072572 @default.
- W4200564508 creator A5058726143 @default.
- W4200564508 creator A5064539315 @default.
- W4200564508 creator A5069357295 @default.
- W4200564508 creator A5070896162 @default.
- W4200564508 creator A5077086947 @default.
- W4200564508 creator A5085053419 @default.
- W4200564508 creator A5086546362 @default.
- W4200564508 date "2021-12-20" @default.
- W4200564508 modified "2023-10-06" @default.
- W4200564508 title "Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors" @default.
- W4200564508 cites W1699538093 @default.
- W4200564508 cites W1968067596 @default.
- W4200564508 cites W1973733861 @default.
- W4200564508 cites W1991548997 @default.
- W4200564508 cites W2020072111 @default.
- W4200564508 cites W2046488302 @default.
- W4200564508 cites W2076994245 @default.
- W4200564508 cites W2095553811 @default.
- W4200564508 cites W2115185064 @default.
- W4200564508 cites W2138104392 @default.
- W4200564508 cites W2139166113 @default.
- W4200564508 cites W2141917844 @default.
- W4200564508 cites W2149501736 @default.
- W4200564508 cites W2169257419 @default.
- W4200564508 cites W2169610187 @default.
- W4200564508 cites W2176154815 @default.
- W4200564508 cites W2325393979 @default.
- W4200564508 cites W2510758757 @default.
- W4200564508 cites W2725317673 @default.
- W4200564508 cites W2740050478 @default.
- W4200564508 cites W2774511679 @default.
- W4200564508 cites W2790187745 @default.
- W4200564508 cites W2804663340 @default.
- W4200564508 cites W2912684492 @default.
- W4200564508 cites W2913212173 @default.
- W4200564508 cites W2918328056 @default.
- W4200564508 cites W2920968061 @default.
- W4200564508 cites W2922036249 @default.
- W4200564508 cites W2923904776 @default.
- W4200564508 cites W2947082286 @default.
- W4200564508 cites W2974137843 @default.
- W4200564508 cites W2979875590 @default.
- W4200564508 cites W2983325814 @default.
- W4200564508 cites W2991022372 @default.
- W4200564508 cites W3004887743 @default.
- W4200564508 cites W3026009801 @default.
- W4200564508 cites W3041066480 @default.
- W4200564508 cites W3081559067 @default.
- W4200564508 cites W3091346137 @default.
- W4200564508 cites W3134466246 @default.
- W4200564508 doi "https://doi.org/10.1371/journal.pone.0261269" @default.
- W4200564508 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34928979" @default.
- W4200564508 hasPublicationYear "2021" @default.
- W4200564508 type Work @default.
- W4200564508 citedByCount "10" @default.
- W4200564508 countsByYear W42005645082022 @default.
- W4200564508 countsByYear W42005645082023 @default.
- W4200564508 crossrefType "journal-article" @default.
- W4200564508 hasAuthorship W4200564508A5007918042 @default.
- W4200564508 hasAuthorship W4200564508A5014126648 @default.
- W4200564508 hasAuthorship W4200564508A5017998451 @default.
- W4200564508 hasAuthorship W4200564508A5021045594 @default.
- W4200564508 hasAuthorship W4200564508A5032072572 @default.
- W4200564508 hasAuthorship W4200564508A5058726143 @default.
- W4200564508 hasAuthorship W4200564508A5064539315 @default.
- W4200564508 hasAuthorship W4200564508A5069357295 @default.
- W4200564508 hasAuthorship W4200564508A5070896162 @default.
- W4200564508 hasAuthorship W4200564508A5077086947 @default.
- W4200564508 hasAuthorship W4200564508A5085053419 @default.
- W4200564508 hasAuthorship W4200564508A5086546362 @default.
- W4200564508 hasBestOaLocation W42005645081 @default.
- W4200564508 hasConcept C104317684 @default.
- W4200564508 hasConcept C111599444 @default.
- W4200564508 hasConcept C111829913 @default.
- W4200564508 hasConcept C135983454 @default.
- W4200564508 hasConcept C137061746 @default.
- W4200564508 hasConcept C159047783 @default.
- W4200564508 hasConcept C202751555 @default.
- W4200564508 hasConcept C202878990 @default.
- W4200564508 hasConcept C2522874641 @default.
- W4200564508 hasConcept C2780575108 @default.
- W4200564508 hasConcept C31972630 @default.
- W4200564508 hasConcept C32470452 @default.
- W4200564508 hasConcept C33602714 @default.
- W4200564508 hasConcept C35693153 @default.
- W4200564508 hasConcept C40767141 @default.
- W4200564508 hasConcept C41008148 @default.
- W4200564508 hasConcept C54355233 @default.
- W4200564508 hasConcept C70721500 @default.
- W4200564508 hasConcept C86803240 @default.
- W4200564508 hasConcept C92087593 @default.